Literature DB >> 23089959

Characterisation of four major histocompatibility complex class II genes of the koala (Phascolarctos cinereus).

Quintin Lau1, Sarah E Jobbins, Katherine Belov, Damien P Higgins.   

Abstract

Major histocompatibility complex (MHC) class II molecules have an integral role in the adaptive immune response, as they bind and present antigenic peptides to T helper lymphocytes. In this study of koalas, species-specific primers were designed to amplify exon 2 of the MHC class II DA and DB genes, which contain much of the peptide-binding regions of the α and β chains. A total of two DA α1 domain variants and eight DA β1 (DAB), three DB α1 and five DB β1 variants were amplified from 20 koalas from two free-living populations from South East Queensland and the Port Macquarie region in northern New South Wales. We detected greater variation in the β1 than in the α1 domains as well as evidence of positive selection in DAB. The present study provides a springboard to future investigation of the role of MHC in disease susceptibility in koalas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089959     DOI: 10.1007/s00251-012-0658-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  39 in total

1.  Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level.

Authors:  Jianzhi Zhang; Rasmus Nielsen; Ziheng Yang
Journal:  Mol Biol Evol       Date:  2005-08-17       Impact factor: 16.240

2.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

3.  Codon-based tests of positive selection, branch lengths, and the evolution of mammalian immune system genes.

Authors:  Austin L Hughes; Robert Friedman
Journal:  Immunogenetics       Date:  2008-06-26       Impact factor: 2.846

4.  Nomenclature for the major histocompatibility complexes of different species: a proposal.

Authors:  J Klein; R E Bontrop; R L Dawkins; H A Erlich; U B Gyllensten; E R Heise; P P Jones; P Parham; E K Wakeland; D I Watkins
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens.

Authors:  F Mazerolles; A Durandy; D Piatier-Tonneau; D Charron; L Montagnier; C Auffray; A Fischer
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  Novel alleles in classical major histocompatibility complex class II loci of the brushtail possum (Trichosurus vulpecula).

Authors:  Olivia J Holland; Phil E Cowan; Dianne M Gleeson; Larry W Chamley
Journal:  Immunogenetics       Date:  2008-06-12       Impact factor: 2.846

8.  The expressed class II alpha-chain genes of the marsupial major histocompatibility complex belong to eutherian mammal gene families.

Authors:  R W Slade; W E Mayer
Journal:  Mol Biol Evol       Date:  1995-05       Impact factor: 16.240

9.  A retrospective study of admission trends of koalas to a rehabilitation facility over 30 years.

Authors:  Joanna E Griffith; Navneet K Dhand; Mark B Krockenberger; Damien P Higgins
Journal:  J Wildl Dis       Date:  2013-01       Impact factor: 1.535

10.  Diversity at the major histocompatibility complex Class II in the platypus, Ornithorhynchus anatinus.

Authors:  Mette Lillie; Rachael E Woodward; Claire E Sanderson; Mark D B Eldridge; Katherine Belov
Journal:  J Hered       Date:  2012-05-04       Impact factor: 2.645

View more
  12 in total

1.  Characterisation of MHC class I genes in the koala.

Authors:  Yuanyuan Cheng; Adam Polkinghorne; Amber Gillett; Elizabeth A Jones; Denis O'Meally; Peter Timms; Katherine Belov
Journal:  Immunogenetics       Date:  2017-07-01       Impact factor: 2.846

2.  Immunomics of the koala (Phascolarctos cinereus).

Authors:  Kendra C Abts; Jamie A Ivy; J Andrew DeWoody
Journal:  Immunogenetics       Date:  2015-03-13       Impact factor: 2.846

3.  MHC class II diversity of koala (Phascolarctos cinereus) populations across their range.

Authors:  Q Lau; W Jaratlerdsiri; J E Griffith; J Gongora; D P Higgins
Journal:  Heredity (Edinb)       Date:  2014-04-02       Impact factor: 3.821

4.  Identification, characterisation and expression analysis of natural killer receptor genes in Chlamydia pecorum infected koalas (Phascolarctos cinereus).

Authors:  Katrina M Morris; Marina Mathew; Courtney Waugh; Beata Ujvari; Peter Timms; Adam Polkinghorne; Katherine Belov
Journal:  BMC Genomics       Date:  2015-10-15       Impact factor: 3.969

5.  Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus).

Authors:  Quintin Lau; Joanna E Griffith; Damien P Higgins
Journal:  PeerJ       Date:  2014-06-19       Impact factor: 2.984

6.  SNP marker discovery in koala TLR genes.

Authors:  Jian Cui; Greta J Frankham; Rebecca N Johnson; Adam Polkinghorne; Peter Timms; Denis O'Meally; Yuanyuan Cheng; Katherine Belov
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

7.  Disentangling the mechanisms of mate choice in a captive koala population.

Authors:  Parice A Brandies; Catherine E Grueber; Jamie A Ivy; Carolyn J Hogg; Katherine Belov
Journal:  PeerJ       Date:  2018-08-21       Impact factor: 2.984

8.  Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infection.

Authors:  Avinash Kollipara; Adam Polkinghorne; Kenneth W Beagley; Peter Timms
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

9.  The relative contribution of causal factors in the transition from infection to clinical chlamydial disease.

Authors:  Bonnie L Quigley; Scott Carver; Jon Hanger; Miranda E Vidgen; Peter Timms
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

10.  Therapeutic vaccination of koalas harbouring endogenous koala retrovirus (KoRV) improves antibody responses and reduces circulating viral load.

Authors:  Olusola Olagoke; Bonnie L Quigley; Farhid Hemmatzadeh; Galit Tzipori; Peter Timms
Journal:  NPJ Vaccines       Date:  2020-07-16       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.